Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 29, 2001

View Archived Issues

MBT Munich Raises EUR30M To Fund Liposomes Platform

Ark Raises #14.5M To Move Three Products Into Phase III

Australian Firms With Cell Lines Get Spark From Bushs Decision

Oxagen, Cerylid Team Up On Endometriosis Genetics Study

Other News To Note

Degussa Pays US$14.3M For Proligo, Invests In Expansion

Galapagos, Vertex Collaborate To Identify Protein Functions

Cerylid Completes A$9.9M Round To Further Develop Pipeline

MorphoSys, CAT Patent Disputes Continue On A Number Of Fronts

A-Viral Recruits In Philippines For Phase II Trial Of AIDS Drug

Oxford GlycoSciences Files NDA For Oral Gaucher Disease Drug